Advertisement
Screener

PETMED EXPRESS, INC. (PETS) Overview

PETMED EXPRESS, INC. (PETS) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.28; Beat / miss (m).
  • 1 Oct 2025: Period ending 31 Dec 2025; Estimate (m); Actual -0.50; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.41; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -1.65; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$1.17$1.50$1.93$2.48$3.19$4.102025-11-062026-11-06$1.17$2.28$4.44$8.66$16.89$32.942021-11-082026-11-06$1.17$2.59$5.75$12.75$28.29$62.752016-11-072026-11-06$1.17$2.76$6.52$15.39$36.34$85.822009-01-022026-11-06$1.17$2.76$6.52$15.39$36.34$85.822009-01-022026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$1.23
Previous close
$1.40
Change
-$0.17
Change (%)
-12.14%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

PETS
-56.25%
S&P 500
(m)

1 year

PETS
-44.22%
S&P 500
(m)

3 years

PETS
-86.34%
S&P 500
(m)

5 years

PETS
-94.34%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.28

-1.73-1.26-0.79-0.320.1531 Dec 2024: estimate (m); actual -0.0331 Dec 2024(m)30 Jun 2025: estimate (m); actual -1.6530 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.4130 Sept 2025(m)31 Dec 2025: estimate (m); actual -0.5031 Dec 2025(m)30 Jun 2026: estimate (m); actual -0.2830 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.28(m)(m)
1 Oct 202531 Dec 2025(m)-0.50(m)(m)
1 Jul 202530 Sept 2025(m)-0.41(m)(m)
1 Apr 202530 Jun 2025(m)-1.65(m)(m)
1 Oct 202431 Dec 2024(m)-0.03(m)(m)

31 Mar 2026 ○ Estimate (m) ● Actual -2.74

-2.82-1.84-0.860.121.1031 Mar 2022: estimate (m); actual 0.9231 Mar 2022(m)31 Mar 2023: estimate (m); actual 0.2531 Mar 2023(m)31 Mar 2024: estimate (m); actual -0.3731 Mar 2024(m)31 Mar 2025: estimate (m); actual -0.3031 Mar 2025(m)31 Mar 2026: estimate (m); actual -2.7431 Mar 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202531 Mar 2026(m)-2.74(m)(m)
1 Apr 202431 Mar 2025(m)-0.30(m)(m)
1 Apr 202331 Mar 2024(m)-0.37(m)(m)
1 Apr 202231 Mar 2023(m)0.25(m)(m)
1 Apr 202131 Mar 2022(m)0.92(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 41.02M ■ Earnings -6.14M — Profit margin -14.98%

-17.14M-27.0%5.56M-20.8%28.26M-14.6%50.95M-8.5%30 Sept 2025: revenue 44.36M; earnings -8.52M; profit margin -19.20%30 Sept 202531 Dec 2025: revenue 40.66M; earnings -10.55M; profit margin -25.95%31 Dec 202531 Mar 2026: revenue 42.82M*; earnings -4.07M*; profit margin -9.49%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2026-01-01 to 2026-03-31; USD.31 Mar 202630 Jun 2026: revenue 41.02M; earnings -6.14M; profit margin -14.98%30 Jun 2026

31 Mar 2026 ■ Revenue 179.02M ■ Earnings -57.29M — Profit margin -32.00%

-97.06M-33.0%39.92M-21.0%176.89M-8.9%313.86M3.1%31 Mar 2023: revenue 247.57M; earnings 5.14M; profit margin 2.08%31 Mar 202331 Mar 2024: revenue 274.10M; earnings -7.46M; profit margin -2.72%31 Mar 202431 Mar 2025: revenue 226.97M; earnings -6.27M; profit margin -2.76%31 Mar 202531 Mar 2026: revenue 179.02M; earnings -57.29M; profit margin -32.00%31 Mar 2026

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$1.23(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$1.23High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning PETS

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-29.28M
Profit margin
-17.34%
Return on assets · 12 month
-33.74%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
189.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
128.46K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-10.83%*
Total return · month
-25.53%*
Total return · quarter
-23.08%*
Total return · half year
-37.22%*
Total return · year to date
-56.25%*
Total return · 1 year
-44.22%*
Total return · 3 years
-86.34%*
Total return · 5 years
-94.34%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$168.86M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

PETMED EXPRESS, INC. Overview

View more →

(m)

(m)

SEC CIK
1040130
Industry (SIC)
5912 Retail-Drug Stores and Proprietary Stores
Country of operation
United States
Business address
420 SOUTH CONGRESS AVENUE, DELRAY BEACH, Florida, 33445, United States
Fiscal year end
0331
Phone
(561) 426-4444

Similar stocks

Stock NameCountryMarket CapPE Ratio
CVS HEALTH Corp (CVS)United States$108.783B27.06